Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-07

Clinical Trial Update: Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating R-CHOP plus metformin in diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • PREDNISONE (Prednisone)
  • R-CHOP
  • Rituximab (rituximab)
  • Vincristine (vincristine)
  • metformin (metformin)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: COMPLETED